E88.3 Tumor lysis syndromeBillable ICD-10-CM code, FY2026. Acts as a Major Complication or Comorbidity (MCC) as a secondary diagnosis.
Defines the logic of DRG(s) 673-675 in MDC 11.
277.88 Tumor lysis syndromeG11 Hereditary ataxia ("metabolic disorders (E70-E88)")G63 Polyneuropathy in diseases classified elsewhere ("metabolic diseases (E70-E88)")G71 Primary disorders of muscles ("metabolic disorders (E70-E88)")H42 Glaucoma in diseases classified elsewhere ("specified metabolic disorder (E70-E88)")N25.0 Renal osteodystrophy ("metabolic disorders classifiable to E70-E88")N25.81 Secondary hyperparathyroidism of renal origin ("metabolic disorders classifiable to E70-E88")P59 Neonatal jaundice from other and unspecified causes ("jaundice due to inborn errors of metabolism (E70-E88)")E88.12 Generalized lipodystrophyE88.13 Localized lipodystrophyE88.14 HIV-associated lipodystrophyE88.19 Other lipodystrophy, not elsewhere classifiedE88.2 Lipomatosis, not elsewhere classifiedE88.3 Tumor lysis syndrome (this code)E88.4 Mitochondrial metabolism disordersE88.40 Mitochondrial metabolism disorder, unspecifiedE88.41 MELAS syndromeE88.42 MERRF syndromeE88.43 Disorders of mitochondrial tRNA synthetases